Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia With Zanubrutinib
For a study, the phase I/II AU-003 research showed that zanubrutinib therapy produces clinically...
Read More
Hematology/Oncology
In Multicentric Castleman Disease-TAFRO, Glycogen Synthase Kinase 3/CCR6-positive Bone Marrow Cells Correlate With Disease Activity
For a study, it was determined that MCD-TAFRO (multicentric Castleman disease–thrombocytopenia,...
Read More
The Prognostic Significance of the TP53 Mutation in Newly Diagnosed Diffuse Large B-cell Lymphoma Patients Enrolled in the FIL-DLCL04 Study
In diffuse large B-cell lymphoma, TP53 disruption has been shown to have a prognostic impact...
Read More
Intubated COVID-19 Patients’ Plasma Microparticles Promote Endothelial Cell Death, Neutrophil Adhesion, and Netosis in a Phosphatidylserine-Dependent Way
For a study, it was determined that COVID-19 had prompted researchers to better understand its...
Read More
Anti-K and Anti-D Alloimmunization of Maternal Red Blood Cells Controlled With Intrauterine Blood Transfusion: Outcome Predictors
For a study, it was determined that the majority of instances of fetal hemolytic illness needing...
Read More
The Role of Anti-HBc Serology in Primary Immune Thrombocytopenia
In primary immune thrombocytopenia (ITP) patients, the relationship between prior hepatitis B...
Read More
Perinatal Outcomes in Sickle Cell Disease Women
There is a scarcity of evidence on current outcomes for pregnant women with sickle cell disease...
Read More
Longitudinal Study of Adherence to Vascular Cell Adhesion Molecule-1 in Sickle Cell Disease at Rest and During Vasa-Occlusive Crises
Sickle cell disease (SCD) is distinguished by the frequent and unpredictability of vaso-occlusive...
Read More
Long-term Effectiveness of First-Line Ibrutinib Therapy in Patients With TP53 Mutations for Chronic Lymphocytic Leukaemia
In patients with chronic lymphocytic leukemia (CLL), TP53 aberrations [del(17p) or TP53 mutation]...
Read More![Correlation of Poly (adenosine diphosphate[ADP]-ribose) Polymerase Expression and Prognosis in Ovarian Cancer: A Systematic Review and Meta-analysis.](https://cdn.physiciansweekly.com/wp-content/uploads/2023/08/woman-lady-yoga-happy-627x376.jpg)
Correlation of Poly (adenosine diphosphate[ADP]-ribose) Polymerase Expression and Prognosis in Ovarian Cancer: A Systematic Review and Meta-analysis.
This meta-analysis evaluated the correlation between poly (adenosine diphosphate [ADP]-ribose)...
Read More
HTN Meds Tied to Lower Mortality After Pancreatic Cancer Diagnosis
FRIDAY, Feb. 25, 2022 (HealthDay News) — Use of angiotensin II receptor blockers (ARBs) and...
Read More
Climate Change Bringing More Catastrophic Wildfires: UN Report
THURSDAY, Feb. 24, 2022 (HealthDay News) — Devastating wildfires around the world will only...
Read More
Women Face Higher Risk for Severe AEs From Cancer Therapy
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Women are at higher risk than men for severe...
Read More
Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — In men receiving treatment for localized...
Read More
Patients Confused, Concerned About Diagnosis, Treatment of DCIS
TUESDAY, Feb. 22, 2022 (HealthDay News) — Patients with ductal carcinoma in situ (DCIS)...
Read More
Circ_0061140 Contributes to the Malignant Progression in Ovarian Cancer Cells by Mediating the RAB1A Level Through Sponging miR-361-5p.
Ovarian cancer (OC) progression is related to many functional molecules, including circular RNAs...
Read More
Brut, Sure Brand Deodorants Under Recall Due to Benzene
FRIDAY, Feb. 18, 2022 (HealthDay News) — Six Brut and Sure aerosol antiperspirant and...
Read More
Daily Aspirin Does Not Prevent Recurrence of Breast Cancer
FRIDAY, Feb. 18, 2022 (HealthDay News) — Regular aspirin use does not improve invasive...
Read More
Scientists Create ‘Universal’ Donor Organs Where Blood Type Does Not Matter
THURSDAY, Feb. 17, 2022 (HealthDay News) — It is possible to create “universal”...
Read More
DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis
THURSDAY, Feb. 17, 2022 (HealthDay News) — For adults with cancer-associated thrombosis...
Read More